CSPG5
Chondroitin sulfate proteoglycan 5
Also known as: CSPG5_HUMAN, NGC
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95196
- Gene
- CSPG5
- Ensembl
- ENSG00000114646
- Chromosome
- 3
- Canonical length
- 566 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Golgi apparatus,Vesicles,Plasma membrane,Cytosol
- Secretome location
- Secreted in brain
OverviewNCBI Gene
The protein encoded by this gene is a proteoglycan that may function as a neural growth and differentiation factor. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2011]
Canonical amino-acid sequenceUniProt
566 residues, UniProt reviewed canonical sequence.
>O95196|CSPG5
1 MGRAGGGGPG RGPPPLLLFL GAALVLASGA VPAREAGSAV EAEELVKGSP AWEPPANDTR
61 EEAGPPAAGE DEASWTAPGG ELAGPEEVLQ ESAAVTGTAW LEADSPGLGG VTAEAGSGDA
121 QALPATLQAP HEVLGQSIMP PAIPEATEAS GPPSPTPGDK LSPASELPKE SPLEVWLNLG
181 GSTPDPQGPE LTYPFQGTLE PQPASDIIDI DYFEGLDGEG RGADLGSFPG SPGTSENHPD
241 TEGETPSWSL LDLYDDFTPF DESDFYPTTS FYDDLDEEEE EEEDDKDAVG GGDLEDENEL
301 LVPTGKPGLG PGTGQPTSRW HAVPPQHTLG SVPGSSIALR PRPGEPGRDL ASSENGTECR
361 SGFVRHNGSC RSVCDLFPSY CHNGGQCYLV ENIGAFCRCN TQDYIWHKGM RCESIITDFQ
421 VMCVAVGSAA LVLLLLFMMT VFFAKKLYLL KTENTKLRRT NKFRTPSELH NDNFSLSTIA
481 EGSHPNVRKL CNTPRTSSPH ARALAHYDNV ICQDDPSAPH KIQEVLKSCL KEEESFNIQN
541 SMSPKLEGGK GDQADLDVNC LQNNLTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CSPG5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.67
- Highest tissue expression
- 103 nTPM
Expression across tissuesHPA
Tissue
- amygdala: 103 nTPM
- cerebral cortex: 98 nTPM
- basal ganglia: 88 nTPM
- hippocampal formation: 73 nTPM
- hypothalamus: 58 nTPM
- choroid plexus: 53 nTPM
Single-cell type
- oligodendrocyte progenitor cells: 319 nCPM
- retinal pigment epithelial cells: 226 nCPM
- müller glia: 108 nCPM
- astrocytes: 84 nCPM
- respiratory ionocytes: 56 nCPM
- alveolar cells type 1: 54 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 95 nTPM
- cerebral cortex: 93 nTPM
- basal ganglia: 87 nTPM
- hippocampal formation: 79 nTPM
- amygdala: 79 nTPM
- hypothalamus: 61 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.65
- gnomAD pLI
- 0.06
- gnomAD missense Z
- 1.34
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell projection morphogenesis
- cytoskeleton organization
- glial cell projection elongation
- intracellular transport
- nervous system development
- positive regulation of substrate adhesion-dependent cell spreading
- regulation of synaptic vesicle exocytosis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Neural chondroitin sulphate proteoglycan cytoplasmic
- CSPG5, sulphate attachment domain
- Chondroitin sulphate attachment domain
- Neural chondroitin sulphate proteoglycan cytoplasmic domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CSPG5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CSPG5 as an antibody target. Whether an autoantibody or antibody against CSPG5 could matter depends on whether native CSPG5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CSPG5 is annotated at the cell surface, where native CSPG5 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CSPG5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...